EDSA - Spark Newswire

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Tuesday, Sept. 21, 2021: HLBZ, XPEV, TOST, IDEX, EDSA

Today, 1:12 PM

Today's 5 Stock Ideas: Helbiz (HLBZ) - Tuesday morning's biggest winner. The stock was up about 120% following news of a company partnership with Amazon (AMZN). XPeng (XPEV) - Company

AMZN

6 minute read

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

By Shanthi Rexaline

Today, 1:12 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)

ABSI

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:12 PM

Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients.

AEI

1 minute read

UPDATE: Zacks Small Cap Research Raises Price Target On Edesa Bio From $16 As Of Sept. 1 To $20

By Benzinga Newsdesk

Today, 1:12 PM

https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_09202021_EDSA_Bautz.pdf

EDSA

1 minute read

Zacks Small Cap Research Issues Report On Edesa Biotech ‘EB05 Reduces Risk of COVID Death by 68.5% in Critically Ill Patients,’ Highlights $20 Price Target

By Benzinga Newsdesk

Today, 1:12 PM

https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_09202021_EDSA_Bautz.pdf

EDSA

3 minute read

Uncategorized

EDSA: EB05 Reduces Risk of COVID Death by 68.5% in Critically Ill Patients…

By Zacks Small Cap Research

Today, 1:12 PM

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT

EDSA

1 minute read

News

Why Edesa Biotech Shares Are Soaring Today

By Adam Eckert

Today, 1:12 PM

Edesa Biotech Inc (NASDAQ: EDSA) is surging higher Monday after the company announced positive Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients. Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over standard

EDSA

2 minute read

Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge

By Lisa Levin

Today, 1:12 PM

Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67.

BRKS

2 minute read

How To Play Edsa Biotech’s Stock After 60% Surge

By Tyler Bundy

Today, 1:12 PM

Edsa Biotech Inc. (NASDAQ: EDSA) shares are trading higher after the company announced Phase 2 Data of its Monoclonal Antibody in hospitalized COVID-19 patients. Critically ill patients demonstrated a 68.5% reduction in risk of dying when treated with EB05 over standard care.

EDSA

1 minute read

Edesa Biotech Stock Is Rallying After COVID-19 Antibody Data: What You Need To Know

By Vandana Singh

Today, 1:12 PM

Edesa Biotech Inc (NASDAQ:EDSA) has announced positive results from the Phase 2 part of an ongoing Phase 2/3 study evaluating EB05…

EDSA

Feed Symbols: EDSA